Consequently, the efficacy of semaglutide 2.4 mg and tirzepatide 15 mg in terms of weight loss effects is extremely significant, highlighted by the fact that approximately 75% of patients treated with semaglutide 2.4 mg or tirzepatide 15 mg experience 10% to 15% body weight loss accompanied by well-known side-effects such as nausea, vomiting, diarrhea and obstipation[ 76 ].
← all excerpts
Prehabilitation of overweight and obese patients with dysglycemia awaiting bariatric surgery: Predicting the success of obesity treatment.
1
—
—